SCRT VS LCRT Followed by PD-L1 Inhibitor Plus CAPEOX as TNT in Patients With LARC
Clinical trial NCT07284992 · RECRUITING
Trial details
- NCT number
- NCT07284992
- Sponsor
- Shandong Provincial Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-12
- Primary completion
- 2028-11-30
- Enrollment
- 208
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.